4//SEC Filing
Gordon Grant 4
Accession 0001303497-06-000038
CIK 0001303497other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 1:34 PM ET
Size
6.9 KB
Accession
0001303497-06-000038
Insider Transaction Report
Form 4
Gordon Grant
Director
Transactions
- Other
Common Stock
2006-06-29−2,500,000→ 5,500,000 total(indirect: GHL Financial Services, Ltd.)
Holdings
- 1
Common Stock
Footnotes (2)
- [F1]GHL transferred 2.5M shares of Common Stock of the Issuer (CS) to Henning Advisors Ltd. on 6.29.06 without consideration, pursuant to a separation of assets agmt. Reporting Person (RP) is Pres. of GHL and does not have investment or voting control and disclaims beneficial ownership over such shares.
- [F2]RP does not have investment or voting control & disclaims beneficial ownership over 150K shares of CS held by Bio Science Ventures #3 & 350K shares of Non-Voting Conv. Pref. Stock of the Issuer held by Anglo-Scotia Holdings, Ltd., as prev. reported by RP on Form 3 & 4 & S-1 of the Issuer (as amended) as filed with the SEC. RP has no investment control & disclaims beneficial ownership over all GHL convertible promissory notes as prev. reported by RP on Form 3 & S-1 of the Issuer (as amended) as filed with the SEC. The notes are held by GHL clients who exercise full investment control over their respective notes. Anglo Scotia & Trika Ltd. holders of 5M & 3M shares of CS of the Issuer, resp., previously changed the name under which they are held to GHL & such shares have been inc. as part of indirect beneficial holdings of RP.
Documents
Issuer
CardioVascular BioTherapeutics, Inc.
CIK 0001303497
Entity typeother
Related Parties
1- filerCIK 0001314769
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 1:34 PM ET
- Size
- 6.9 KB